Solara Active Pharma Sciences Limited has informed the Exchange about audio recording of Q2 FY26 earnings call held on November 05, 2025.

Corporate Office: Solara Active Pharma Sciences Limited TICEL Bio Park, 6th Floor, Module No. 601, 602, 603, Phase II – CSIR Road, Taramani, Chennai, Tamil Nadu – 600113. Tel: +91 44 47406700 Fax: +91 44 47406190 E-mail: investors@solara.co.in www.solara.co.in

November 05, 2025

The BSE Limited Phiroze Jeejeebhoy Towers Dalal Street, Mumbai – 400 001 Scrip Code: 541540, 890202

The National Stock Exchange of India Limited Exchange Plaza, Bandra-Kurla Complex Bandra (E), Mumbai – 400 051 Symbol: SOLARA, SOLARAPP1

Dear Sir / Madam,

Subject: Audio recordings of Q2 of FY26 earnings call conducted on November 05, 2025 for the quarter and half year ended September 30, 2025

Pursuant to Regulation 30 and 46 read with clause 15 of Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby confirm that we have uploaded audio recording of the Q2 of FY26 Earnings Call held on November 05, 2025, on our Company’s website under the heading Investor relations/Stock Exchange Communication/ Investor update.

Link for audio recording of Conference call is given below:

solara.co.in/uploads/2025/11/10036336.mp3

This is for your information and records.

Thanking you,

Yours faithfully, For Solara Active Pharma Sciences Limited

Pooja Jaya Kumar Company Secretary & Compliance Officer Membership No.: A57415

Registered Office: 9th Floor, ‘Cyber One’, Unit No. 902, Plot No. 4 & 6, Sector 30A, Vashi, Navi Mumbai - 400 703; Tel: +91-22-2517 2163

Solara Active Pharma Sciences Limited - CIN: L24230MH2017PLC291636